FLT3-ITD MUTATION

Clinical trials for FLT3-ITD MUTATION explained in plain language.

Never miss a new study

Get alerted when new FLT3-ITD MUTATION trials appear

Sign up with your email to follow new studies for FLT3-ITD MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for AML patients: targeted drug may outperform standard care after transplant

Disease control Recruiting now

This study tests whether the drug gilteritinib works better than sorafenib at keeping leukemia from coming back in people with a specific genetic mutation (FLT3-ITD) after a stem cell transplant. About 594 participants will be randomly assigned to take one of the two drugs for up…

Matched conditions: FLT3-ITD MUTATION

Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated May 17, 2026 02:58 UTC

FLT3-ITD MUTATION

Get alerted when new FLT3-ITD MUTATION trials appear

New hope for AML patients: targeted drug may outperform standard care after transplant